NEW YORK, November 29, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Quest Diagnostics Inc. (NYSE: DGX), Cigna Corp. (NYSE: CI), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Theravance Inc. (NASDAQ: THRX), and Volcano Corporation (NASDAQ: VOLC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Quest Diagnostics Inc. Research Report
On November 26, 2013, Quest Diagnostics Inc. (Quest Diagnostics) reported that it will present at the Piper Jaffray 25th Annual Healthcare Conference in New York City, in which the Company's President and CEO Steve Rusckowski will review Quest Diagnostics' vision, goals and five-point strategy. The Company informed that the presentation is scheduled for Tuesday, December 3, 2013, at 9:30 a.m. ET. Quest Diagnostics informed that the live webcast of the presentation will be available on the Company website. The Company added that archive of the live webcast, two hours following the conclusion of the live event, can be accessed at the Company's website until January 2, 2014. The Full Research Report on Quest Diagnostics Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Cigna Corp. Research Report
On November 26, 2013, Cigna Corp. (Cigna) announced that the Company, along with Kent Hospital, has entered into a multi-year contract that adds the hospital and its employed physicians to Cigna's network of participating hospitals and doctors in Rhode Island, with effect from December 1, 2013. Cigna stated that with effect of this contract, its customers receiving health care services from Kent Hospital or its doctors are now covered at the in-network benefit level, in accordance to the terms of their health care benefits plan. Don Curry, Cigna's President and General Manager for New England, commented, "We welcome Kent Hospital to the Cigna network and are pleased that our Rhode Island customers will now have more options available when they need access to quality health care." Sandra L. Coletta, Chief Operating Officer, Care New England and President and CEO, Kent Hospital, added, "Kent Hospital's partnership with Cigna means that more people will have access to an extensive array of health care services. Helping more people to be healthy and live healthy lives is always an excellent outcome." The Full Research Report on Cigna Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Arena Pharmaceuticals, Inc. Research Report
On November 26, 2013, Arena Pharmaceuticals, Inc.'s (Arena) stock increased 5.44%, ending the day at $6.40. Over the previous three trading sessions, shares of Arena increased 11.89% compared to the Nasdaq Composite which also increased 1.22% during the same period. The Full Research Report on Arena Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Theravance Inc. Research Report
On November 21, 2013, Theravance Inc. (Theravance) reported that it will participate at the 25th Annual Piper Jaffray Healthcare Conference to be held on December 3 to December 4, 2013 at The New York Palace, New York City, New York. Theravance stated that its CEO, Rick E Winningham, will present on Tuesday, December 3, 2013, at 9:30 a.m. EST, and the live webcast of the presentation will be available at the Company's website. The Full Research Report on Theravance Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Volcano Corporation Research Report
On November 25, 2013, Volcano Corporation (Volcano) reported that it will take part in the Piper Jaffray 25th Annual Health Care Conference on Tuesday, December 3, 2013. The Company stated that the presentation will be given by Scott Huennekens, President and CEO, which is slated to start at 1:00 p.m. EST (10:00 a.m. PST). Volcano added that the presentation can be accessed via the Company's website. The Full Research Report on Volcano Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner